Affiliate disclosure: This article contains affiliate links. If you buy through them, we may earn a commission at no extra cost to you. This does not influence our assessment of the evidence below.
Evidence rating: Preliminary — Ginkgo biloba has genuinely strong randomized evidence for dizziness, but most of the rest of this formula is metabolic, not vestibular
What Vertigenics Claims To Be
Vertigenics is a two-capsule-daily supplement marketed for vertigo, balance and brain health. The positioning is unusual: vertigo is one of the more specific complaints a supplement can target, and unlike vague “wellness” claims it points at a measurable outcome that clinical trials actually use.
Which makes the ingredient list surprising when you read it.
What’s Actually In It
Between the published ingredients document and the official site, fifteen components are named:
- Berberine HCl (100 mg per serving — the only disclosed dose)
- Ginkgo biloba
- Alpha-lipoic acid
- Ginger root extract
- Korean ginseng
- L-theanine
- Magnesium
- Vitamin B6
- Zinc
- Chromium
- Green tea leaf extract
- Resveratrol
- Milk thistle
- Cayenne fruit
- Banana leaf (banaba)
Set aside the ginkgo, ginger and L-theanine and look at what’s left: berberine at 100 mg, chromium, banaba, alpha-lipoic acid, green tea, milk thistle. That is the standard ingredient roster of a blood sugar support formula. The official site’s own descriptions reinforce this — berberine is described there in terms of metabolic health, blood pressure and cholesterol; milk thistle in terms of liver detoxification. Neither has anything to do with the vestibular system.
That mismatch is the central fact about this product, and I’d rather lead with it than bury it.
What The Research Shows
According to PubMed, one ingredient here has excellent evidence for the advertised outcome.
Ginkgo performed as well as a prescription vertigo drug in a 160-person trial. A multicenter randomized double-blind study assigned patients with vertigo (mean age 58) to either standardised Ginkgo biloba extract EGb 761 at 240 mg/day or betahistine at 32 mg/day — betahistine being a mainstream prescription treatment for vestibular disorders — for twelve weeks. Both groups improved on every outcome measure, with no significant difference between them. Clinical global impression was rated “very much” or “much improved” in 79% of the ginkgo group versus 70% on betahistine, and ginkgo produced fewer adverse events (27 across 19 patients versus 39 across 31). DOI
A second, independent head-to-head found the same thing. An 86-patient randomized double-blind trial published in 2026 compared EGb 761 at 120 mg/day against betahistine at 36 mg/day over twelve weeks in people with dizziness or vertigo of unclear cause. Both improved significantly over time with no group-by-time interaction — meaning comparable efficacy. Betahistine had a transient edge on the Dizziness Handicap Inventory at week two, but by week twelve there was no significant difference. Both were well tolerated. DOI
Two independent randomized trials showing a botanical matching a prescription drug on the target symptom is a genuinely strong result, and it is the reason this product gets a passing evidence rating at all.
Ginger, by contrast, was tested on the vestibular system and failed. A double-blind controlled study measured nystagmus — the involuntary eye movement that is the objective signature of vestibular stimulation — after subjects took powdered ginger root, placebo, or dimenhydrinate. Ginger’s effect did not differ from baseline or placebo on caloric, rotatory or optokinetic nystagmus. Dimenhydrinate reduced the response as expected. The authors concluded that ginger does not act on the vestibular or oculomotor systems at all, and that whatever anti-nausea effect it has must come from the stomach instead. DOI
Alpha-lipoic acid has nerve data, though not balance data. A systematic review of 27 randomized trials in diabetic peripheral neuropathy found alpha-lipoic acid significantly reduced total symptom scores — by 2.45 points with 600 mg intravenous and 1.95 points with 600 mg oral. DOI A later meta-analysis of nine trials in 1,153 patients found alpha-lipoic acid combined with epalrestat and mecobalamin improved nerve conduction velocities more than mono- or dual therapy. DOI This is real evidence for peripheral nerve function in diabetes. It is not evidence for vertigo, and the oral doses used were 600 mg — a level this formula, sharing capsule space with fourteen other ingredients, is unlikely to reach.
For berberine, chromium, banaba, milk thistle, resveratrol, cayenne, Korean ginseng, zinc and green tea I found no randomized human trials for vertigo, dizziness or balance outcomes.
The Honest Verdict
What holds up: Ginkgo biloba for dizziness and vertigo, and it holds up well — two independent randomized double-blind trials, both against an active prescription comparator rather than placebo, both showing equivalence, both showing good tolerability. If you were building a vertigo supplement from the evidence up, ginkgo is what you’d start with.
What doesn’t: Nearly everything else, relative to the claim. Ginger was directly tested against the vestibular system and showed no effect — that’s not an absence of evidence, that’s evidence of absence for this specific mechanism. Alpha-lipoic acid’s real support is in diabetic neuropathy at doses this formula almost certainly doesn’t reach. And roughly half the label is a glycemic-support stack that appears to have wandered in from a different product.
The bigger practical problem is dosing. The trials that worked used 120–240 mg/day of a standardised ginkgo extract, EGb 761, with a defined chemical profile. Vertigenics discloses a dose for exactly one ingredient — berberine, at 100 mg — and nothing for the ginkgo. There is no way to tell whether you’re getting a trial-relevant amount.
Who this makes sense for: Someone with mild, chronic, already-investigated dizziness who wants to try ginkgo and would rather take it inside a broader formula. Honestly, though, a standardised EGb 761 ginkgo product at a known dose would give you the evidence-backed ingredient without the fourteen passengers.
Who should skip it: Anyone with new, sudden, severe or worsening vertigo — that needs a doctor, not a supplement, because the causes range from benign positional vertigo to things that are not benign at all. Anyone on blood thinners (ginkgo has bleeding-risk interactions). And anyone on glucose-lowering medication, who should note that this “vertigo formula” contains berberine, chromium and banaba and could plausibly affect their blood sugar.
Check current pricing and availability
View Vertigenics on the official site
This article is for informational purposes only and is not medical advice. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration. Talk to your physician before starting any supplement, especially if you have a diagnosed condition or take medication.
Research cited via PubMed:
- Sokolova L, et al. Int J Otolaryngol. 2014;2014:682439. DOI
- Jianbunjongkit N, et al. J Otolaryngol Head Neck Surg. 2026;55:19160216251407927. DOI
- Holtmann S, et al. Acta Otolaryngol. 1989;108(3-4):168-74. DOI
- Çakici N, et al. Diabet Med. 2016;33(11):1466-1476. DOI
- Ran GL, et al. J Diabetes Complications. 2024;38(2):108691. DOI